Calcium Antagonists Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1552987 No. of Pages: 72 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.
CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.
This report aims to provide a comprehensive presentation of the global market for Calcium Antagonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Antagonists. This report contains market size and forecasts of Calcium Antagonists in global, including the following market information:
Global Calcium Antagonists Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Calcium Antagonists Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Calcium Antagonists companies in 2022 (%)
The global Calcium Antagonists market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Dihydropyridine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Calcium Antagonists include Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Calcium Antagonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Calcium Antagonists Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Calcium Antagonists Market Segment Percentages, by Type, 2022 (%)
Dihydropyridine
Diltiazem
Verapamil
Others
Global Calcium Antagonists Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Calcium Antagonists Market Segment Percentages, by Application, 2022 (%)
Hypertension
Coronary Artery Disease
Arrhythmia
Ohers
Global Calcium Antagonists Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Calcium Antagonists Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Calcium Antagonists revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Calcium Antagonists revenues share in global market, 2022 (%)
Key companies Calcium Antagonists sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Calcium Antagonists sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku
Outline of Major Chapters:
Chapter 1: Introduces the definition of Calcium Antagonists, market overview.
Chapter 2: Global Calcium Antagonists market size in revenue and volume.
Chapter 3: Detailed analysis of Calcium Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Calcium Antagonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Calcium Antagonists capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Calcium Antagonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Calcium Antagonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Calcium Antagonists Overall Market Size
2.1 Global Calcium Antagonists Market Size: 2022 VS 2029
2.2 Global Calcium Antagonists Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Calcium Antagonists Sales: 2018-2029
3 Company Landscape
3.1 Top Calcium Antagonists Players in Global Market
3.2 Top Global Calcium Antagonists Companies Ranked by Revenue
3.3 Global Calcium Antagonists Revenue by Companies
3.4 Global Calcium Antagonists Sales by Companies
3.5 Global Calcium Antagonists Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Calcium Antagonists Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Calcium Antagonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Calcium Antagonists Players in Global Market
3.8.1 List of Global Tier 1 Calcium Antagonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Calcium Antagonists Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Calcium Antagonists Market Size Markets, 2022 & 2029
4.1.2 Dihydropyridine
4.1.3 Diltiazem
4.1.4 Verapamil
4.1.5 Others
4.2 By Type - Global Calcium Antagonists Revenue & Forecasts
4.2.1 By Type - Global Calcium Antagonists Revenue, 2018-2023
4.2.2 By Type - Global Calcium Antagonists Revenue, 2024-2029
4.2.3 By Type - Global Calcium Antagonists Revenue Market Share, 2018-2029
4.3 By Type - Global Calcium Antagonists Sales & Forecasts
4.3.1 By Type - Global Calcium Antagonists Sales, 2018-2023
4.3.2 By Type - Global Calcium Antagonists Sales, 2024-2029
4.3.3 By Type - Global Calcium Antagonists Sales Market Share, 2018-2029
4.4 By Type - Global Calcium Antagonists Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Calcium Antagonists Market Size, 2022 & 2029
5.1.2 Hypertension
5.1.3 Coronary Artery Disease
5.1.4 Arrhythmia
5.1.5 Ohers
5.2 By Application - Global Calcium Antagonists Revenue & Forecasts
5.2.1 By Application - Global Calcium Antagonists Revenue, 2018-2023
5.2.2 By Application - Global Calcium Antagonists Revenue, 2024-2029
5.2.3 By Application - Global Calcium Antagonists Revenue Market Share, 2018-2029
5.3 By Application - Global Calcium Antagonists Sales & Forecasts
5.3.1 By Application - Global Calcium Antagonists Sales, 2018-2023
5.3.2 By Application - Global Calcium Antagonists Sales, 2024-2029
5.3.3 By Application - Global Calcium Antagonists Sales Market Share, 2018-2029
5.4 By Application - Global Calcium Antagonists Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Calcium Antagonists Market Size, 2022 & 2029
6.2 By Region - Global Calcium Antagonists Revenue & Forecasts
6.2.1 By Region - Global Calcium Antagonists Revenue, 2018-2023
6.2.2 By Region - Global Calcium Antagonists Revenue, 2024-2029
6.2.3 By Region - Global Calcium Antagonists Revenue Market Share, 2018-2029
6.3 By Region - Global Calcium Antagonists Sales & Forecasts
6.3.1 By Region - Global Calcium Antagonists Sales, 2018-2023
6.3.2 By Region - Global Calcium Antagonists Sales, 2024-2029
6.3.3 By Region - Global Calcium Antagonists Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Calcium Antagonists Revenue, 2018-2029
6.4.2 By Country - North America Calcium Antagonists Sales, 2018-2029
6.4.3 US Calcium Antagonists Market Size, 2018-2029
6.4.4 Canada Calcium Antagonists Market Size, 2018-2029
6.4.5 Mexico Calcium Antagonists Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Calcium Antagonists Revenue, 2018-2029
6.5.2 By Country - Europe Calcium Antagonists Sales, 2018-2029
6.5.3 Germany Calcium Antagonists Market Size, 2018-2029
6.5.4 France Calcium Antagonists Market Size, 2018-2029
6.5.5 U.K. Calcium Antagonists Market Size, 2018-2029
6.5.6 Italy Calcium Antagonists Market Size, 2018-2029
6.5.7 Russia Calcium Antagonists Market Size, 2018-2029
6.5.8 Nordic Countries Calcium Antagonists Market Size, 2018-2029
6.5.9 Benelux Calcium Antagonists Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Calcium Antagonists Revenue, 2018-2029
6.6.2 By Region - Asia Calcium Antagonists Sales, 2018-2029
6.6.3 China Calcium Antagonists Market Size, 2018-2029
6.6.4 Japan Calcium Antagonists Market Size, 2018-2029
6.6.5 South Korea Calcium Antagonists Market Size, 2018-2029
6.6.6 Southeast Asia Calcium Antagonists Market Size, 2018-2029
6.6.7 India Calcium Antagonists Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Calcium Antagonists Revenue, 2018-2029
6.7.2 By Country - South America Calcium Antagonists Sales, 2018-2029
6.7.3 Brazil Calcium Antagonists Market Size, 2018-2029
6.7.4 Argentina Calcium Antagonists Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Calcium Antagonists Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Calcium Antagonists Sales, 2018-2029
6.8.3 Turkey Calcium Antagonists Market Size, 2018-2029
6.8.4 Israel Calcium Antagonists Market Size, 2018-2029
6.8.5 Saudi Arabia Calcium Antagonists Market Size, 2018-2029
6.8.6 UAE Calcium Antagonists Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Calcium Antagonists Major Product Offerings
7.1.4 Pfizer Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Aventis
7.2.1 Aventis Company Summary
7.2.2 Aventis Business Overview
7.2.3 Aventis Calcium Antagonists Major Product Offerings
7.2.4 Aventis Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.2.5 Aventis Key News & Latest Developments
7.3 Searle
7.3.1 Searle Company Summary
7.3.2 Searle Business Overview
7.3.3 Searle Calcium Antagonists Major Product Offerings
7.3.4 Searle Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.3.5 Searle Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Calcium Antagonists Major Product Offerings
7.4.4 Bayer Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Calcium Antagonists Major Product Offerings
7.5.4 AstraZeneca Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Knoll Pharmaceuticals
7.6.1 Knoll Pharmaceuticals Company Summary
7.6.2 Knoll Pharmaceuticals Business Overview
7.6.3 Knoll Pharmaceuticals Calcium Antagonists Major Product Offerings
7.6.4 Knoll Pharmaceuticals Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.6.5 Knoll Pharmaceuticals Key News & Latest Developments
7.7 Wyeth-Ayerst
7.7.1 Wyeth-Ayerst Company Summary
7.7.2 Wyeth-Ayerst Business Overview
7.7.3 Wyeth-Ayerst Calcium Antagonists Major Product Offerings
7.7.4 Wyeth-Ayerst Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.7.5 Wyeth-Ayerst Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Calcium Antagonists Major Product Offerings
7.8.4 Novartis Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Calcium Antagonists Major Product Offerings
7.9.4 Sanofi Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
7.10 Baiyunshan Pharmaceutical
7.10.1 Baiyunshan Pharmaceutical Company Summary
7.10.2 Baiyunshan Pharmaceutical Business Overview
7.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Major Product Offerings
7.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.10.5 Baiyunshan Pharmaceutical Key News & Latest Developments
7.11 South China Pharmaceutical Group
7.11.1 South China Pharmaceutical Group Company Summary
7.11.2 South China Pharmaceutical Group Calcium Antagonists Business Overview
7.11.3 South China Pharmaceutical Group Calcium Antagonists Major Product Offerings
7.11.4 South China Pharmaceutical Group Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.11.5 South China Pharmaceutical Group Key News & Latest Developments
7.12 Tianjin Tanabe Seiyaku
7.12.1 Tianjin Tanabe Seiyaku Company Summary
7.12.2 Tianjin Tanabe Seiyaku Calcium Antagonists Business Overview
7.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Major Product Offerings
7.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Sales and Revenue in Global (2018-2023)
7.12.5 Tianjin Tanabe Seiyaku Key News & Latest Developments
8 Global Calcium Antagonists Production Capacity, Analysis
8.1 Global Calcium Antagonists Production Capacity, 2018-2029
8.2 Calcium Antagonists Production Capacity of Key Manufacturers in Global Market
8.3 Global Calcium Antagonists Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Calcium Antagonists Supply Chain Analysis
10.1 Calcium Antagonists Industry Value Chain
10.2 Calcium Antagonists Upstream Market
10.3 Calcium Antagonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Calcium Antagonists Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com